company background image
603676 logo

Tibet Weixinkang Medicine SHSE:603676 Stock Report

Last Price

CN¥8.62

Market Cap

CN¥3.8b

7D

5.0%

1Y

-35.6%

Updated

13 Jun, 2024

Data

Company Financials

Tibet Weixinkang Medicine Co., Ltd.

SHSE:603676 Stock Report

Market Cap: CN¥3.8b

603676 Stock Overview

Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.

603676 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Tibet Weixinkang Medicine Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tibet Weixinkang Medicine
Historical stock prices
Current Share PriceCN¥8.62
52 Week HighCN¥14.35
52 Week LowCN¥6.30
Beta0.063
1 Month Change-10.40%
3 Month Change1.29%
1 Year Change-35.58%
3 Year Change10.51%
5 Year Change-19.51%
Change since IPO8.29%

Recent News & Updates

Take Care Before Diving Into The Deep End On Tibet Weixinkang Medicine Co., Ltd. (SHSE:603676)

Apr 16
Take Care Before Diving Into The Deep End On Tibet Weixinkang Medicine Co., Ltd. (SHSE:603676)

Recent updates

Take Care Before Diving Into The Deep End On Tibet Weixinkang Medicine Co., Ltd. (SHSE:603676)

Apr 16
Take Care Before Diving Into The Deep End On Tibet Weixinkang Medicine Co., Ltd. (SHSE:603676)

Shareholder Returns

603676CN PharmaceuticalsCN Market
7D5.0%-0.8%-0.9%
1Y-35.6%-9.9%-14.4%

Return vs Industry: 603676 underperformed the CN Pharmaceuticals industry which returned -9.9% over the past year.

Return vs Market: 603676 underperformed the CN Market which returned -14.4% over the past year.

Price Volatility

Is 603676's price volatile compared to industry and market?
603676 volatility
603676 Average Weekly Movement6.2%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 603676 has not had significant price volatility in the past 3 months.

Volatility Over Time: 603676's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006701Yong Zhangwww.wxkpharma.com

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases, and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd.

Tibet Weixinkang Medicine Co., Ltd. Fundamentals Summary

How do Tibet Weixinkang Medicine's earnings and revenue compare to its market cap?
603676 fundamental statistics
Market capCN¥3.79b
Earnings (TTM)CN¥248.69m
Revenue (TTM)CN¥1.29b

15.1x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603676 income statement (TTM)
RevenueCN¥1.29b
Cost of RevenueCN¥621.92m
Gross ProfitCN¥668.19m
Other ExpensesCN¥419.51m
EarningsCN¥248.69m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.57
Gross Margin51.79%
Net Profit Margin19.28%
Debt/Equity Ratio0%

How did 603676 perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

49%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.